Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today ... The report's release coincides with Rare Disease Day, a global initiative to raise awareness and generate support ...

CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled ... GBS is a rare disorder in which the body’s immune system attacks the peripheral nervous system, leading to symptoms ...

The life-altering consequences of GBS were recently detailed in a new patient survey released by the GBS/CIDP Foundation that ... patients with cold agglutinin disease (CAD) for up to four weeks ...

Myelin seems to be the primary target of the immune attack in these disorders ... (EAN), which resembles GBS, and describe four clinical syndromes in detail: GBS, CIDP, MMN, and nonsystemic ...

Unlike many other autoimmune disorders, CIDP and GBS are more prevalent in males than in females ... Nonetheless, a Japanese study identified male sex, longer disease duration, and slower progression ...

The new mom was diagnosed with a rare disease called Guillain-Barré Syndrome ... the executive director of GBS/CIDP Foundation of Canada. Helm considers herself a survivor. She is now using her time ...

and the GBS | CIDP Foundation International. Their backing signals the critical importance of such legislation and the positive impact it promises for thousands of Americans with rare diseases.

Research on peripheral neuropathies, especially GBS, CIDP, or CMT is receiving increased attention ... nerve cells controlling muscles for swallowing), and Hirschsprung’s disease (loss of nervous ...